Global and China Parkinson's Disease Treatments Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Dopamine Agonists
  • 1.2.3 Levodopa
  • 1.2.4 Glutamate Antagonist
  • 1.2.5 Apomorphine
  • 1.2.6 COMT Inhibitors Anticholinergics
  • 1.2.7 MAO-B Inhibitors
  • 1.2.8 Other Drugs
• 1.3 Market by Application
  • 1.3.1 Global Parkinson's Disease Treatments Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospitals
  • 1.3.3 Healthcare Institutes
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Parkinson's Disease Treatments Market Perspective (2015-2026)
• 2.2 Global Parkinson's Disease Treatments Growth Trends by Regions
  • 2.2.1 Parkinson's Disease Treatments Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Parkinson's Disease Treatments Historic Market Share by Regions (2015-2020)
  • 2.2.3 Parkinson's Disease Treatments Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Parkinson's Disease Treatments Players by Market Size
  • 3.1.1 Global Top Parkinson's Disease Treatments Players by Revenue (2015-2020)
  • 3.1.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2015-2020)
• 3.2 Global Parkinson's Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Parkinson's Disease Treatments Revenue
• 3.4 Global Parkinson's Disease Treatments Market Concentration Ratio
  • 3.4.1 Global Parkinson's Disease Treatments Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Treatments Revenue in 2019
• 3.5 Key Players Parkinson's Disease Treatments Area Served
• 3.6 Key Players Parkinson's Disease Treatments Product Solution and Service
• 3.7 Date of Enter into Parkinson's Disease Treatments Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Parkinson's Disease Treatments Breakdown Data by Type (2015-2026)

• 4.1 Global Parkinson's Disease Treatments Historic Market Size by Type (2015-2020)
• 4.2 Global Parkinson's Disease Treatments Forecasted Market Size by Type (2021-2026)

5 Parkinson's Disease Treatments Breakdown Data by Application (2015-2026)

• 5.1 Global Parkinson's Disease Treatments Historic Market Size by Application (2015-2020)
• 5.2 Global Parkinson's Disease Treatments Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Parkinson's Disease Treatments Market Size (2015-2026)
• 6.2 North America Parkinson's Disease Treatments Market Size by Type (2015-2020)
• 6.3 North America Parkinson's Disease Treatments Market Size by Application (2015-2020)
• 6.4 North America Parkinson's Disease Treatments Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Parkinson's Disease Treatments Market Size (2015-2026)
• 7.2 Europe Parkinson's Disease Treatments Market Size by Type (2015-2020)
• 7.3 Europe Parkinson's Disease Treatments Market Size by Application (2015-2020)
• 7.4 Europe Parkinson's Disease Treatments Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Parkinson's Disease Treatments Market Size (2015-2026)
• 8.2 China Parkinson's Disease Treatments Market Size by Type (2015-2020)
• 8.3 China Parkinson's Disease Treatments Market Size by Application (2015-2020)
• 8.4 China Parkinson's Disease Treatments Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Parkinson's Disease Treatments Market Size (2015-2026)
• 9.2 Japan Parkinson's Disease Treatments Market Size by Type (2015-2020)
• 9.3 Japan Parkinson's Disease Treatments Market Size by Application (2015-2020)
• 9.4 Japan Parkinson's Disease Treatments Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Parkinson's Disease Treatments Market Size (2015-2026)
• 10.2 Southeast Asia Parkinson's Disease Treatments Market Size by Type (2015-2020)
• 10.3 Southeast Asia Parkinson's Disease Treatments Market Size by Application (2015-2020)
• 10.4 Southeast Asia Parkinson's Disease Treatments Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 GSK
  • 11.1.1 GSK Company Details
  • 11.1.2 GSK Business Overview
  • 11.1.3 GSK Parkinson's Disease Treatments Introduction
  • 11.1.4 GSK Revenue in Parkinson's Disease Treatments Business (2015-2020))
  • 11.1.5 GSK Recent Development
• 11.2 Merck
  • 11.2.1 Merck Company Details
  • 11.2.2 Merck Business Overview
  • 11.2.3 Merck Parkinson's Disease Treatments Introduction
  • 11.2.4 Merck Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 11.2.5 Merck Recent Development
• 11.3 Novartis
  • 11.3.1 Novartis Company Details
  • 11.3.2 Novartis Business Overview
  • 11.3.3 Novartis Parkinson's Disease Treatments Introduction
  • 11.3.4 Novartis Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 11.3.5 Novartis Recent Development
• 11.4 Teva
  • 11.4.1 Teva Company Details
  • 11.4.2 Teva Business Overview
  • 11.4.3 Teva Parkinson's Disease Treatments Introduction
  • 11.4.4 Teva Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 11.4.5 Teva Recent Development
• 11.5 Boehringer Ingelheim
  • 11.5.1 Boehringer Ingelheim Company Details
  • 11.5.2 Boehringer Ingelheim Business Overview
  • 11.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Introduction
  • 11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 11.5.5 Boehringer Ingelheim Recent Development
• 11.6 Impax
  • 11.6.1 Impax Company Details
  • 11.6.2 Impax Business Overview
  • 11.6.3 Impax Parkinson's Disease Treatments Introduction
  • 11.6.4 Impax Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 11.6.5 Impax Recent Development
• 11.7 Abbvie
  • 11.7.1 Abbvie Company Details
  • 11.7.2 Abbvie Business Overview
  • 11.7.3 Abbvie Parkinson's Disease Treatments Introduction
  • 11.7.4 Abbvie Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 11.7.5 Abbvie Recent Development
• 11.8 Bausch Health
  • 11.8.1 Bausch Health Company Details
  • 11.8.2 Bausch Health Business Overview
  • 11.8.3 Bausch Health Parkinson's Disease Treatments Introduction
  • 11.8.4 Bausch Health Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 11.8.5 Bausch Health Recent Development
• 11.9 Lundbeck
  • 11.9.1 Lundbeck Company Details
  • 11.9.2 Lundbeck Business Overview
  • 11.9.3 Lundbeck Parkinson's Disease Treatments Introduction
  • 11.9.4 Lundbeck Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 11.9.5 Lundbeck Recent Development
• 11.10 Sun Pharma
  • 11.10.1 Sun Pharma Company Details
  • 11.10.2 Sun Pharma Business Overview
  • 11.10.3 Sun Pharma Parkinson's Disease Treatments Introduction
  • 11.10.4 Sun Pharma Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 11.10.5 Sun Pharma Recent Development
• 11.11 Wockhardt
  • 10.11.1 Wockhardt Company Details
  • 10.11.2 Wockhardt Business Overview
  • 10.11.3 Wockhardt Parkinson's Disease Treatments Introduction
  • 10.11.4 Wockhardt Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 10.11.5 Wockhardt Recent Development
• 11.12 Acadia
  • 10.12.1 Acadia Company Details
  • 10.12.2 Acadia Business Overview
  • 10.12.3 Acadia Parkinson's Disease Treatments Introduction
  • 10.12.4 Acadia Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 10.12.5 Acadia Recent Development
• 11.13 UCB
  • 10.13.1 UCB Company Details
  • 10.13.2 UCB Business Overview
  • 10.13.3 UCB Parkinson's Disease Treatments Introduction
  • 10.13.4 UCB Revenue in Parkinson's Disease Treatments Business (2015-2020)
  • 10.13.5 UCB Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer